Microbiome, dysbiosis and use of probiotics in various diseases

doi:10.5501/wjv.v14.i2.99574

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

HTML

Tables (1-1)

Sum=12

Jun 25, 2025 (publication date) through Jun 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Jun 25, 2025; 14(2): 99574
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.99574

Microbiome, dysbiosis and use of probiotics in various diseases

Ece Tüsüz Önata, Öner Özdemir

Ece Tüsüz Önata, Öner Özdemir, Division of Allergy and Immunology, Department of Pediatrics, Sakarya Research and Training Hospital, Sakarya University, Faculty of Medicine, Sakarya 54100, Türkiye

Author contributions: Tüsüz Önata E and Özdemir Ö have done everything; all of the authors read and approved the final version of the manuscript to be published.

Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Öner Özdemir, MD, Professor, Division of Allergy and Immunology, Department of Pediatrics, Sakarya Research and Training Hospital, Sakarya University, Faculty of Medicine, Adnan Menderes Cad, Sağlık Sok, No. 195 Adapazarı, Sakarya 54100, Türkiye. onerozdemir@sakarya.edu.tr

Received: July 25, 2024
Revised: December 18, 2024
Accepted: January 2, 2025
Published online: June 25, 2025
Processing time: 332 Days and 23.5 Hours

Core Tip

Core Tip: Dysbiosis refers to compositional and functional changes in the microbiota that cause disruption of the resistance and resilience of the microbial ecosystem. Correction of dysbiosis by beneficial bacteria such as probiotics can be a useful treatment for allergic diseases.